SCHEMBL17875951

SCHEMBL17875951

O=S1(=O)Cc2cc(-c3cccc4oc5ccccc5c34)ccc2-c2cc(-c3cccc4oc5ccccc5c34)ccc2C1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 2/20 0.35
NQO1 P15559 1/20 0.33
MEN1 O00255 3/20 0.33
KMT2A Q03164 3/20 0.33
BACE1 P56817 1/20 0.32
MAOA P21397 2/20 0.31
PLA2G2A P14555 2/20 0.31
PLA2G4A P47712 2/20 0.31
PRKDC P78527 1/20 0.31
KDM4E B2RXH2 3/20 0.31
ALDH1A1 P00352 3/20 0.31
MAPT P10636 3/20 0.31
HPGD P15428 3/20 0.31
SMN1; SMN2 Q16637 2/20 0.31
GLA P06280 1/20 0.31
CYP3A4 P08684 1/20 0.31
PGAM1 P18669 1/20 0.31
CASP1 P29466 1/20 0.31
CASP7 P55210 1/20 0.31
HSD17B10 Q99714 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17876005 0.95 ALOX5 (0.38) ALOX5NQO1MEN1KMT2ABACE1
SCHEMBL17875949 0.94 HSP90AA1 (0.35) ALOX5NQO1MEN1KMT2ABACE1
SCHEMBL17875942 0.94 HSP90AA1 (0.35) ALOX5NQO1MEN1KMT2ABACE1
SCHEMBL17875950 0.94 PRKDC (0.37) ALOX5NQO1MEN1KMT2ABACE1
SCHEMBL17875935 0.94 PRKDC (0.37) ALOX5NQO1MEN1KMT2ABACE1
SCHEMBL17875952 0.93 PLA2G2A (0.37) ALOX5NQO1MEN1KMT2APLA2G2A
SCHEMBL17875948 0.93 ALOX5 (0.46) ALOX5NQO1PRKDCCDC14BCDC14A
SCHEMBL17875958 0.93 PLA2G2A (0.37) ALOX5NQO1MEN1KMT2APLA2G2A
SCHEMBL17875930 0.93 ALOX5 (0.46) ALOX5NQO1PRKDCCDC14BCDC14A
SCHEMBL17876002 0.89 MEN1 (0.38) ALOX5MEN1KMT2ABACE1PLA2G2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10581000-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-03-03 US disclosed
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-06-30 US disclosed
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-06-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10581000-B2 Condensed cyclic compound and organic light-emitting device including the same CRY1, CRY2, CCNE2 ALOX5 3059/4885NQO1 851/4885MEN1 448/4885
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNE2 ALOX5 3059/4885NQO1 851/4885MEN1 448/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.